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Purpose: This report examines the blood chemistry and blood pressure (BP) results from the 
Lifestyle Education for Activity and Nutrition (LEAN) study, a randomized weight loss trial. 
A primary purpose of the study was to evaluate the effects of real-time self-monitoring of 
energy balance (using the SenseWearTM Armband, BodyMedia, Inc Pittsburgh, PA) on these 
health factors.
Methods: 164 sedentary overweight or obese adults (46.8 ± 10.8 years; BMI 33.3 ± 5.2 kg/m2; 
80% women) took part in the 9-month study. Participants were randomized into 4 conditions: 
a standard care condition with an evidence-based weight loss manual (n = 40), a group-based 
behavioral weight loss program (n = 44), an armband alone condition (n = 41), and a group plus 
armband (n = 39) condition. BP, fasting blood lipids and glucose were measured at baseline 
and 9 months.
Results: 99 participants (60%) completed both baseline and follow-up measurements for BP 
and blood chemistry analysis. Missing data were handled by baseline carried forward. None 
of the intervention groups had significant changes in blood lipids or BP when compared to 
standard care after adjustment for covariates, though within-group lowering was found for 
systolic BP in group and group + armband conditions, a rise in total cholesterol and LDL 
were found in standard care and group conditions, and a lowering of triglycerides was found 
in the two armband conditions. Compared with the standard care condition, fasting glucose 
decreased significantly for participants in the group, armband, and group + armband conditions 
(all P , 0.05), respectively.
Conclusion: Our results suggest that using an armband program is an effective strategy to 
decrease fasting blood glucose. This indicates that devices, such as the armband, can be a success-
ful way to disseminate programs that can improve health risk factors. This can be accomplished 
without group-based behavioral programs, thereby potentially reducing costs.
Keywords: armband, energy balance, randomized controlled trial, physical activity, blood 
lipids, blood glucose
Introduction
Prior reports of participation in physical activity (PA) interventions1–5 have observed 
favorable changes in physiological risk factors. These reports led to the 2008 publication 
of the “Physical Activity Guidelines for Americans,” which documents that most health 
benefits result from at least 150 minutes of moderate activity a week, 75 minutes of 
vigorous activity a week, or a combination of the two along with two or more days of 
muscle-strengthening activities that work all major muscle groups.6 Risk factors such as 
elevated levels of blood pressure (BP), blood lipids, and glucose play an important role 
in determining risk of developing chronic diseases or death.7–11 Prior PA intervention Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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studies using technology tools (eg,   pedometers) have used 
paper-based materials, such as in the First Step Program,12 or 
have used groups to teach cognitive and behavioral strategies 
to increase PA.13 Fewer studies have utilized technology-
based approaches to promote weight loss and PA.14–18 It is 
important to examine new methods using the latest technol-
ogy to provide feedback to participants in a study that is 
readily available, and flexible to their goals. The ability to 
use real-time feedback monitoring of energy expenditure 
may be a useful strategy to enable success in a wide variety 
of populations through its interactive nature, and must be 
studied more closely.
To our knowledge, relatively few   randomized controlled 
trials (RCT) have examined technology-based weight loss 
approaches to improve BP, blood lipids, and glucose.12,14,16,17,19,20 
The Lifestyle Education for Activity and Nutrition (LEAN) 
study was a 9 month RCT to determine the effectiveness of 
using the SenseWearTM Armband (BodyMedia, Inc Pittsburgh, 
PA) for weight loss among 164 sedentary and overweight or 
obese individuals. While weight loss was the primary out-
come of LEAN, BP, blood lipids, and fasting glucose were 
a priori secondary outcomes.21 The LEAN study provided 
an opportunity to examine the effects of various weight loss 
approaches on these selected cardiometabolic factors. There-
fore, the primary aim of this report was to examine changes in 
BP, fasting blood lipids, and fasting glucose across different 
intervention   conditions. Findings from this study will further 
our understanding of utilizing real-time self-monitoring devices 
on physiological outcomes.19
Methods
Study design
A complete description of the LEAN study design and meth-
ods appears elsewhere.21 In brief, the study was a RCT with 
a standard care control condition and 3 treatment conditions. 
The treatment conditions consisted of a group behavioral 
change intervention based on the transtheoretical model 
and social cognitive theory22 (group), an armband alone 
condition (armband), and a combined group-based weight 
loss intervention and armband condition (group + armband). 
The research protocol was reviewed and approved annually 
by the University of South Carolina Institutional Review 
Board. Written informed consent was obtained from all 
participants.
Study participants
Thorough descriptions of the recruiting and screening pro-
cesses, as well as the methods are available.21 Briefly, the 
study was limited to men and women aged 18 to 65 years who 
were sedentary (not accumulating 150 minutes of moderate 
to vigorous PA throughout the week in bouts $10 minutes), 
overweight or obese (body mass index [BMI] between 
25.0–45.0 kg/m2), and with access to the internet. Exclu-
sion criteria included significant weight loss (.20 lbs) in 
the prior 6 months; elevated BP ($160/95 mm Hg); current 
participation in a formal weight loss program; using medica-
tions that affect weight; and ailments, medical conditions or 
other issues (eg, pregnancy) that limit PA or would prevent 
participants from adhering to the protocol. Individuals with 
a score of 16 or more on the Center for Epidemiological 
Studies Depression scale were excluded based on data from 
other studies demonstrating that depressed mood is associ-
ated with attrition from weight loss programs.23 Participants 
were recruited from the greater Columbia, South Carolina 
area from February 2008 to January 2009.
Outcomes
All LEAN study staff were trained by the same supervisor 
to minimize inter-technician variability. Blood lipids and 
glucose were measured at baseline and 9-month assessment 
visits. Participants were instructed to fast (ie, no food or 
drink after midnight, besides water) for these assessments. 
All blood draws occurred between 7.00 am and 9.30 am and 
were taken from the antecubital vein. Serum samples were 
processed and analyzed using standardized procedures by 
a Versamax microplate reader (Molecular Devices, Inc, 
Sunnyvale, CA) using Pointe Scientific, Inc (Canton, MI) 
reagents and standards, to measure total cholesterol (TC), 
high-density lipoprotein (HDL), and triglycerides. Very-low-
density lipoprotein (VLDL) was first calculated by dividing 
the triglyceride count by 5. Then the following equation was 
used to calculate low-density lipoprotein (LDL):
  TC − HDL − VLDL = LDL  (1)
Three supine readings of BP were taken alternately after 
a 5-minute supine resting period and averaged. BP was 
measured using calibrated mercury sphygmomanometers 
following the JNC7 protocol.24
Other measures
Body weight to the nearest 0.25 lbs was assessed using a 
calibrated balance-beam scale. Height to the nearest 16th 
of an inch was assessed using a wall-mounted stadiometer. 
Smoking history and medication use were assessed by 
responses on detailed medical history questionnaires and 
reviewed by a physician.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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intervention
Participants were randomly assigned to either the standard 
care control condition or to one of the intervention conditions: 
group, armband, or group + armband.
Standard Care: These participants received a self-directed 
weight loss manual based on two evidence-based programs, 
Active Living Every Day (ALED)25 and Healthy Eating 
Every Day (HEED).26 The manual’s focus was to help indi-
viduals adopt healthful eating patterns and increase their PA 
levels. Cognitive and behavioral strategies consistent with 
the transtheoretical model and social cognitive theory were 
emphasized.27,28 All study participants received this manual.
Group: During the 9-month intervention, participants received 
14 group sessions during the first 4 months, then 6 one-on-
one telephone counseling sessions over the final 5 months. 
Each group session followed the ALED and HEED curricu-
lum format from the manual, with the addition of a weekly 
weigh-in and more content directly related to weight loss. The 
one-on-one telephone counseling sessions were designed to 
promote the maintenance of behavior change.
Armband: The armband condition received the SenseWearTM 
platform consisting of the SenseWearTM Armband, a wrist 
watch with real-time display, and access to a personalized 
Weight Management Solutions web account. While wearing 
the armband and wrist watch display, participants received 
real-time feedback on several outcomes (ie, energy expendi-
ture, minutes spent in moderate and vigorous PA, steps per 
day, progress towards goals). Feedback could be reviewed 
graphically (eg, energy intake, energy balance, and weight 
loss) as participants regularly downloaded their PA data 
and recorded daily energy intake and body weight to the 
Weight Management Solutions web account. Participants 
were asked to wear the armband at least 16 hours a day, 
7 days a week.
Group + Armband: These participants received all com-
ponents of the group condition with the addition of the 
SenseWearTM platform in the armband condition.
Participant retention, adherence, blinded 
assessment, and randomization
To facilitate retention and adherence, participants com-
pleted a 2-week pre-randomization run-in period and 
received a printed list of study requirements and expecta-
tions.   Participants were compensated for completion of the 
baseline and month 4 assessment (US $10) and month 9 
assessment (US $15), totaling US $25. Assessment personnel 
were blinded to intervention assignment. Participants were 
reminded not to discuss their condition assignment with the 
assessment team. Randomization assignment was computer 
generated and conducted by the statistician.
Statistical analysis
Descriptive baseline characteristics for conditions were 
tabulated as means and standard deviations (SD) or as 
  percentages. Differences in blood chemistry and BP changes 
within and across conditions were tested by analysis of 
covariance with adjustment for baseline age, gender, race, 
education, recruitment wave, and baseline lipid values. 
  Furthermore, BP and lipid measures were adjusted for base-
line medications affecting the respective outcomes. An α 
level of 0.05 was used because it was an a priori intention 
to compare only the differences between the intervention 
conditions and the standard care condition.21 Results are 
presented as adjusted means with standard error (SE) or 95% 
confidence intervals (CI).
For comparison, all outcomes were tested using only 
available data, without using baseline values carried forward 
for missing follow-up data. The results from these analyses 
did not differ substantially from the analyses with baseline 
values carried forward. For presentation herein, we report 
the baseline observation carried forward analyses using 
SAS statistical software, version 9.2 (SAS Inc, Cary, North 
Carolina).
Results
A total of 787 telephone screening calls were completed. 
Based on exclusion and inclusion criteria, 590 potential 
participants (75%) were ineligible (Figure 1). After giving 
informed consent, 197 (25%) were randomized, of whom 
164 (83%) had complete data at baseline. One hundred and 
four (63%) completed the study with 99 providing usable 
follow-up data (60%). Baseline values were carried forward 
for missing data or dropouts, so data from 164 of 197 partici-
pants (83%) were included in the primary analyses.
The mean age was 47.6 ± 10.7 (SD) years and mean 
BMI 33.2 ± 5.3 (SD) kg/m2 for the participants in the 
study population, with 31.1% being African American 
(Table 1). About a third (31.1%) of the participants took 
medication for hypertension, and 26.8% were currently 
prescribed lipid lowering medication. Very few participants 
were taking medication for high blood glucose (7.3%). 
Only 4.9% of participants were current smokers, and a high 
percentage of participants (77.4%) were college graduates. 
Cardiovascular risk factors were within normal ranges.
Table 2 presents the changes in BP and lipid variables. 
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787 Individuals screened
510 Individuals eligible for
orientation visit 
50 Randomized to Standard Care
197  Randomized
277 Ineligible or not interested
2 For age criteria
84 For BMI <25 or >45
32 For being too active
54 For medical exclusions
10 For internet access
48 For weight loss exclusions
13 For activity limitations
34 Declined to participate/other 272 Excluded
5 For BMI <25 or >45
36 For medical exclusions
20 For CESD
211 Declined to participate/other 238 Individuals eligible for
run-in visits
224 Individuals eligible
for baseline visit
14 Excluded
3 For blood pressure
4 For activity logs         
7 Declined to participate/other
27 Excluded
3 For BMI <25 or >45         
24 Declined to participate/other
49 Randomized to Group
25 Completed Trial 28 Completed Trial
23 Follow-up Blood available 24 Follow-up Blood available
40 Included in primary analysis 44 Included in primary analysis
40 Completed Baseline Blood
Draw 
44 Completed Baseline Blood
Draw 
49 Randomized to Group+Armband
27 Completed Trial
26 Follow-up Blood available
39 Included in primary analysis
39 Completed Baseline Blood
Draw 
49 Randomized to Armband
24 Completed Trial
26 Follow-up Blood available
41 Included in primary analysis
41 Completed Baseline Blood
Draw 
Figure 1 consolidated Standards of reporting Trials (cOnSOrT) diagram describing recruitment and retention of participants. if follow-up blood chemistry were missing, 
baseline values were carried forward.
intervention conditions had significant changes in BP or 
lipids in analyses adjusted for baseline value, age, gender, race, 
education, medication, and recruitment wave. When groups 
were stratified by medication, these results did not differ (data 
not shown). Lower systolic blood pressures were found within 
the group (−2.96 mm Hg) and group + armband (−3.48 mm 
Hg) conditions (all P , 0.05). Significant within-group 
increases of TC and LDL were found in standard care (TC 
change, 18.32 mg/dL; LDL change, 15.84 mg/dL) and group 
(TC change, 15.58 mg/dL; LDL change, 13.71 mg/dL) condi-
tions, respectively (all P , 0.05). There were also significant 
within-group decreases in triglycerides in both the armband 
(−13.07 mg/dL) and group + armband (−19.87 mg/dL) condi-
tions (all P , 0.05).
Figure 2 shows the mean change for fasting glucose for all 
conditions. Due to the low number of participants taking medi-
cation for blood glucose (n = 12), those persons were excluded  , 
leaving 152 in the analysis. All values represent the least-squares 
means adjusted for age, gender, race, education, recruitment 
wave, and baseline glucose level. Compared with the standard 
care condition, mean glucose decreased by 5.42 mg/dL in 
the group condition, 8.88 mg/dL in the armband condition, 
and 12.59 mg/dL in the group + armband condition. Pairwise 
comparisons between standard care and group, armband, and 
group + armband conditions were significant (P , 0.05).
Discussion
The primary finding from this RCT was a favorable reduction 
in fasting glucose in the treatment conditions. All treatment 
conditions showed a significant reduction when compared 
with the standard care condition. Only within-group condi-
tions for group and group + armband were found for lower 
blood pressure. Other changes included within group lower-
ing of triglycerides for the armband and group + armband 
treatments. Though not anticipated, the standard care and 
group treatments had unexpected higher TC and LDL values Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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Table 1 Baseline characteristics*
Characteristics Total  
(n = 164)
Standard care  
(n = 40)
Group  
(n = 44)
Armband  
(n = 41)
Group + Armband   
(n = 39)
Age (years) 47.6 (10.7) 47.8 (9.0) 46.8 (12.4) 49.2 (11.4) 46.6 (9.6)
Female, no. (%) 132 (80.5) 33 (82.5) 35 (79.6) 32 (78.1) 32 (82.1)
African American, no. (%) 51 (31.1) 15 (37.5) 13 (29.6) 12 (29.3) 11 (28.2)
college degree or  
higher, no. (%)
127 (77.4) 31 (77.5) 35 (79.6) 32 (78.1) 29 (74.4)
Body mass index (kg/m2) 33.2 (5.3) 33.9 (5.6) 32.8 (4.9) 33.4 (5.7) 32.7 (5.0)
Resting blood pressure (mmHg)
Systolic  127 (12) 129 (13) 126 (11) 129 (13) 125 (12)
Diastolic  81 (8) 82 (9) 79 (8) 81 (8) 79 (7)
Fasting plasma lipids (mg/dL)
Total cholesterol 173.3 (44.2) 171.8 (34.2) 170.8 (48.3) 178.1 (47.5) 172.5 (46.1)
hDL 47.8 (19.4) 48.5 (20.3) 47.5 (18.8) 45.4 (19.5) 50.2 (19.4)
LDL 105.5 (42.5) 102.5 (33.0) 103.2 (46.2) 111.2 (45.2) 105.2 (44.8)
Triglycerides 99.6 (64.9) 103.9 (67.7) 100.6 (66.5) 107.6 (71.5) 85.6 (51.6)
Fasting blood glucose (mg/dL) 97.7 (24.8) 99.1 (18.3) 104.0 (29.6) 98.0 (21.9) 88.8 (26.0)
current smoker, no. (%) 8 (4.9) 4 (10) 1 (2.3) 2 (4.9) 1 (2.6)
Current medication, No. (%)
hypertension 51 (31.1) 11 (27.5) 11 (25.0) 16 (39.0) 13 (33.3)
Diabetes mellitus 12 (7.3) 1 (2.5) 5 (11.4) 4 (9.8) 2 (5.1)
Lipids lowering medication† 44 (26.8) 7 (17.5) 13 (29.6) 15 (36.6) 9 (23.1)
Notes: *Data presented as mean (standard deviation) unless otherwise indicated. †Lipids lowering medication includes Statin and triglycerides-medications.
Abbreviations: hDL, high-density lipoprotein; LDL, low-density lipoprotein.
SI conversions: To convert LDL and hDL to mmol/L, multiply by 0.0259; triglycerides to mmol/L, multiply by 0.0113; fasting glucose to mmol/L, multiply by 0.0555. 
Table 2 change in blood pressure and lipids*
Characteristics Standard care  
(n = 40)
Group  
(n = 44)
Armband  
(n = 41)
Group + armband  
(n = 39)
P-Value†
change in resting systolic BP (mm hg) 0.57 (1.18) −2.96 (1.12)‡ −2.24 (1.16) −3.48 (1.20)‡ 0.08
change in resting diastolic BP (mm hg) −0.01 (0.79) −0.42 (0.75) −0.83 (0.78) −1.41 (0.80) 0.64
change in total cholesterol (mg/dL) 18.32 (5.57)‡ 15.58 (5.28)‡ 3.06 (5.50) 3.61 (5.62) 0.11
change in hDL (mg/dL) 2.66 (2.63) 3.28 (2.50) 3.52 (2.60) 3.33 (2.66) 1.00
change in LDL (mg/dL) 15.84 (5.30)‡ 13.71 (5.02)‡ 2.67 (5.23) 3.96 (5.34) 0.18
change in triglycerides (mg/dL) −1.34 (6.72) −7.68 (6.36) −13.07 (6.61)‡ −19.87 (6.81)‡ 0.26
Notes: *Values are least-squares means (Se) adjusted for baseline age, gender, race, education, recruitment wave, medication, and baseline blood pressure or lipids value. 
†Differences in blood lipids change across groups (row P values), ‡within-groups were tested by analysis of covariance (AncOVA) (P , 0.05), and § Significant across group 
differences were followed by pair-wise comparisons to test whether intervention groups differed significantly from the standard care group (P , 0.05).
Abbreviations: BP, blood pressure; hDL, high-density lipoprotein; LDL, low-density lipoprotein; Se, standard error.
after 9 months. We speculate that this may have resulted   
from a change or discontinuation of medications, not follow-
ing the fasting procedures, body weight changes, or other 
unknown causes. No differences were found between the group 
intervention, the armband alone, or a combination of the two 
on glucose. Overall, these findings suggest that a technology-
based intervention with an armband, used as a real-time 
self-monitoring device, is a sufficient behavior change strategy 
for reducing fasting blood glucose after 9 months.
Comparison to other studies
Several studies incorporating technology-based devices 
using real-time feedback in their behavioral change strategies 
have focused on PA and weight changes in their designs.15,18 
Few studies have included cardiometabolic changes.12,14,16,17,19,20 
Of these, an internet-based RCT using Active Living Every 
Day (ALED) and pedometers found reductions in triglycerides 
(P = 0.01) and slight reductions in LDL and TC, resulting in 
a lower coronary risk ratio (CRR). Fasting glucose in this 
16 week study did not change (P = 0.92).14 Our study followed 
participants for a substantially longer time period, which could 
account for the reduction in blood glucose   measures. In the 
First Step Program (FSP), a pedometer-based intervention, 
47 overweight/obese sedentary individuals increased their 
activity at 16 and 24 weeks, but no significant changes were 
noted for glycemia, BP, or cholesterol values.12 In a study by 
de Greef et al,16 41 type 2 diabetics were randomized to a 
control group or an   intervention group consisting of 5 group Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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Figure 2 Mean change (least-squares mean ± 95% confidence interval) in fasting 
glucose for the standard care and intervention groups. Difference across groups 
were tested by analysis of covariance (ANCOVA) with adjustment for prespecified 
covariates (baseline age, gender, race, education, recruitment wave, and baseline 
glucose)  among  152  participants  not  taking  glucose  medication.  Significant 
AncOVAs (P , 0.05) were followed by pair-wise comparisons to test whether 
intervention groups differed significantly from the standard care group. 
Notes: *The P-values for pairwise comparisons of standard care with the armband, 
group, and group + armband were P , 0.05 for each.
sessions in 12 weeks, and a booster session at 22 weeks plus 
a pedometer. At the 1-year follow up, results indicated no 
significant changes in TC or BP, but there was a significant 
decrease in HbA1c within both groups,16 which agrees with 
our findings. Lastly, in the “Walking for Wellbeing in the 
West” study, while triglycerides and glucose were not mea-
sured, no differences were found for TC, HDL, or BP between 
or within the intervention or control groups.17 Overall, our 
findings are comparable with the existing literature.12,14,16,17,19,20 
Most studies found no changes to cholesterol levels.12,16,17,19,20 
Our findings for glycemic values agreed with one study we 
reviewed that dealt with technology,16 but not with findings 
of other studies.12,14,17,19 Even so, it is recognized that being 
physically active is associated with reducing glucose levels.29 
We found very little change in BP values, which was consistent 
with the studies presented.12,14,16,17
The technology-based real-time monitoring used in LEAN 
is an example of a new type of self-monitoring. Traditional 
paper-based PA self-monitoring has demonstrated benefits 
in the past.12,30 With the advent of technological resources 
and the widespread availability of computers and web-based 
cell phones, the shift from paper to more advanced devices 
can provide flexibility in how data such as PA measures and 
energy expenditure are displayed and used for reinforcement 
of behavior change. Augmenting weight-loss interventions 
with real-time measurements and increased accessibility   
to PA history supports cognitive restraint from sedentary 
  behaviors or improper food consumption by integrating 
constant reinforcement toward program goals.30 The value and 
success of using technology-based methods may be attribut-
able to the interactive experience associated with accessing 
information. This methodology can support users via tailored 
feedback and cues to assess and enhance their PA levels while 
tracking progress toward personalized goals. Further study on 
this tailoring is needed to enhance PA behavior change and 
maintain adherence to healthy lifestyle programs.
Physiological mechanisms
PA is known to influence several factors that may lower the 
levels of fasting blood glucose. Of primary importance is 
increasing insulin sensitivity and decreasing insulin resis-
tance, resulting in improved metabolic responses when 
shuttling nutrients for glucose storage and usage.31,32 Habitual 
exercise has also been shown to increase citrate synthase and 
cellular GLUT-4 protein expression, each of which increases 
the uptake of glucose into the skeletal muscle.33,34 This can 
directly clear glucose more effectively from the blood stream. 
Weight loss itself has also been linked to lower glucose 
levels in the blood.35 These physiologic responses together 
can explain why lower levels of fasting glucose were found. 
Modest blood pressure reduction has been found with those 
participating in regular exercise, though persons who are 
in stage 1 or 2 hypertension may benefit more than those 
who are normotensive.36 Due to our population being in 
the latter category, we did not find great reductions in 
BP values. Greater improvements in these cardiometabolic 
risk factors may be more likely seen in those with either 
consistent or higher levels of energy expenditure in com-
bination with diet interventions such as those in the HEED 
program materials.26
Strengths and limitations
This study had several strengths, including the randomized 
design, the blinding of assessment staff to group assignments, 
the moderate length of follow-up, the quantitative measures 
used to assess the outcomes, and the large proportion of 
  African Americans, lending diversity to our study popula-
tion. This study was structured to allow comparisons with 
4 different conditions, allowing detailed comparisons among 
different treatment modalities, including historically suc-
cessful and future strategies. These results have probable 
implications for future commercialization and community 
interest in a minimal contact, widely dispersible alternative 
to group-based weight loss campaigns, which are relatively Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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expensive. Our results may stimulate new intervention 
approaches to increase PA, with the result of lowering fast-
ing glucose.
Limitations include large attrition rates in the standard 
care group (48% attrition rate), though this was similar in 
all groups. Most of the participants in the LEAN study were 
female (82%), and had a high level of education (college 
or above, 77%). This limits our results to similar popula-
tions. Information on changes or end of study prescription 
medication for BP, lipids, or glucose was not available. This 
may present a concern from internal validity threats due to 
the confounding nature of these substances on our outcome 
measures. However, assumptions were made that few persons 
on medication would enter or exit medication therapy or have 
their prescription changed dramatically. Due to costs, we only 
measured the cardiometabolic risk factors at baseline and 
month 9. We were not able to examine the relationship of the 
glucose, or the other values, with time. We suggest that future 
studies allow for several measurement points to investigate 
this relationship when using technology-based methods.
Conclusions
In this study of sedentary, overweight or obese men and 
women, all three treatments using group or armband condi-
tions reduced fasting glucose levels when compared with 
standard care. No changes were found for BP or blood 
lipids between the standard care and treatment conditions. 
Our study suggests that the incorporation of armband tech-
nology into weight loss interventions can be an effective 
strategy to lower fasting glucose. This illustrates the value 
of utilizing real-time self-monitoring systems for measur-
ing energy expenditure in future programs. Automated 
devices, such as the armband, can be a successful way to 
disseminate healthy lifestyle programs that can improve 
important health risk factors. This can be accomplished 
without group-based behavioral programs, thereby poten-
tially reducing costs.
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